ImmunityBio, Inc.
Biotechnology company · San Diego, California, United States · Nasdaq: IBRX
ImmunityBio, Inc. is a biotechnology company headquartered in San Diego, California, United States. Its shares trade on Nasdaq under the ticker IBRX. It has reported private securities offerings to the US SEC, most recently $470 million sold in a notice filed in 2023.
ImmunityBio at a glance
What does ImmunityBio do?
Private fundraising reported to the SEC
9 Form D notices; the most recent reported $470 million sold (2023).
A site under this name is registered with the FDA by Altor BioScience, LLC, an indirect wholly-owned subsidiary of ImmunityBio, Inc..
Frequently asked questions about ImmunityBio
Where is ImmunityBio headquartered?
ImmunityBio, Inc. is headquartered in San Diego, California, United States.
What does ImmunityBio do?
ImmunityBio, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is ImmunityBio a public company?
Yes. ImmunityBio, Inc. trades on Nasdaq under the ticker IBRX.
Similar companies
- Biolinq IncSan Diego, California, United States
- BioAtla, Inc.San Diego, California, United States
- Neurocrine Biosciences IncSan Diego, California, United States
- Sorrento Therapeutics, Inc.San Diego, California, United States
- Protego Biopharma, Inc.San Diego, California, United States
- Tempo Therapeutics, Inc.San Diego, California, United States
- Fate Therapeutics IncSan Diego, California, United States
- ImageneBio, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.